Pfizer Unveils Upjohn Global HQ In China Amid Unprecedented Pressure On Pricing
In an effort to get closer to customers, Pfizer opens Upjohn global headquarters in Shanghai amid a fast-changing environment, the US-China trade standoff and potentially increased price erosion.
You may also be interested in...
Products old, new and reimbursed were the driving force for foreign drug firms including AstraZeneca, Merck and Pfizer and Sanofi to smash growth in China in the first quarter.
Facing deep price erosion and fierce competition for their established products, more multinational firms are hopping on the digital health train in China, with Merck KGaA and Pfizer becoming the latest to tie up with the country's internet giants Tencent and AliHealth, respectively.
In a bold move to expand into cancer treatment markets, Siemens Healthineers has agreed to a $16.4bn all-cash deal to acquire radiation therapy leader Varian.